Lung UltrasoundNCT07574255
3D-US Construct on Volumetric Assessment of Lung Disease & Clinical Application
An observational study of Lung Ultrasound and Lung Cancer (Diagnosis), run by National Taiwan University Hospital at 1 site in Taiwan.
Trial summary
The goal of this observational study is to establish the three-dimensional construct of lung lesion via ultrasound in patients with peripheral lung lesions or any superficial lesion in thoracic fields. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Lung Ultrasound, Lung Cancer (Diagnosis), Peripheral Lung Lesions
- How many people
- 300 participants
- Where
- 1 siteTaiwan
- Study dates
- 30 May 2026to 28 Feb 2031
- How long will I take part?
- 6 Months
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Participants with peripheral lung lesions or with lesions located at superficial thoracic field will be recruited from referral cases for ultrasound workup
Who may be able to join
- Participants suspect with lung lesions referred for ultrasound workup
Who cannot join
- Participants aged < 18 years
- Participants refusal
- Participants with implanted metal in scanning area interfering data collection
- Participants who cannot perform breath holding for at least 1 second
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
YAO-WEN KUO, Ph.D contact
Taiwan1 site
National Taiwan University Hospital
Taipei
YEN-LIN CHEN, Doctor of Medicine
About this study
Official title: Three-dimensional Ultrasonic Construct on Volumetric Assessment of Lung Disease and Its Clinical Application
The goal of this observational study is to establish the three-dimensional construct of lung lesion via ultrasound in patients with peripheral lung lesions or any superficial lesion in thoracic fields. The primary question our study aims to answer is:
Whether the 3D ultrasound morphology can reflect lung disease entities? Whether the 3D volumetric follow-up protocol can be standardised to reflect lung disease status?
- Keywords
- lung ultrasound, three-dimensional ultrasound, peripheral lung lesions
- Medical subject headings
- Lung Neoplasms, Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| ultrasound work-up | participants with peripheral lesions, not confined to lung, referred for ultrasound workup |
What is being measured
The primary outcome is the main question the study is designed to answer.
volume of measured lesion
Standard volume will be defined by computed tomography measurement, and the ultrasound 3D-volmetric result would be compared
Measured: from enrollment, every 6 weeks until 24th week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 May 2026
- Study start30 May 2026 (estimated)
- Primary completion28 Feb 2031 (estimated)
- Study completion28 Feb 2031 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Lung UltrasoundStudies of the same condition, open and under way.
- More trials run by National Taiwan University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 300 participants (estimated)
- Target duration
- 6 Months
Sponsor and investigators
- Lead sponsor
- National Taiwan University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- YEN-LIN CHEN, Doctor of Medicine, Principal investigator, National Taiwan University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07574255
- Sponsor's protocol ID
- 202604005DIND
- Status last verified
- May 2026
- First submitted
- 3 May 2026
- Last updated
- 7 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual data may contain images with unremovable personal information, which may violate the Personal Data Protection Act.
Study at a glance
From the registry record, last updated by the sponsor on 7 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Three-dimensional Ultrasonic Construct on Volumetric Assessment of Lung Disease and Its Clinical Application
- ClinicalTrials.gov ID
- NCT07574255
- Acronym / sponsor ID
- 202604005DIND
- Keywords
- lung ultrasound, three-dimensional ultrasound, peripheral lung lesions
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 300 participants (estimated)
- Lead sponsor
- National Taiwan University HospitalUniversity, hospital or other
- Study start
- 30 May 2026 (estimated)
- Primary completion
- 28 Feb 2031 (estimated)
- Study completion
- 28 Feb 2031 (estimated)
- First posted
- 7 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this observational study is to establish the three-dimensional construct of lung lesion via ultrasound in patients with peripheral lung lesions or any superficial lesion in thoracic fields. The primary question our study aims to answer is:
Whether the 3D ultrasound morphology can reflect lung disease entities? Whether the 3D volumetric follow-up protocol can be standardised to reflect lung disease status?
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 6 Months
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| ultrasound work-up | – | –participants with peripheral lesions, not confined to lung, referred for ultrasound workup |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Participants with peripheral lung lesions or with lesions located at superficial thoracic field will be recruited from referral cases for ultrasound workup
Key inclusion criteria (1 listed)
- Participants suspect with lung lesions referred for ultrasound workup
Key exclusion criteria (4 listed)
- Participants aged < 18 years
- Participants refusal
- Participants with implanted metal in scanning area interfering data collection
- Participants who cannot perform breath holding for at least 1 second
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
volume of measured lesion
Time frame: from enrollment, every 6 weeks until 24th week
Standard volume will be defined by computed tomography measurement, and the ultrasound 3D-volmetric result would be compared
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 May 2026.
- Individual participant dataSharing planned: No. Individual data may contain images with unremovable personal information, which may violate the Personal Data Protection Act.
Related trials for Lung Ultrasound
Not yet recruiting
Expanded Diagnostic Strategy in Older Adults Hospitalized With Community-Acquired Acute Respiratory Infection
Acute Respiratory Infection
Not yet recruitingObservational study
Preoperative Gastric Ultrasound and Anaesthetic Management in Patients Undergoing Coronary Artery Bypass Grafting
Preoperative Fasting, Pulmonary Aspiration During Anesthetic Induction
Not yet recruitingObservational study
Ultrasound Findings in a Pediatric Population
Respiratory Tract Infections (RTI), Lung Ultrasound
Active, not recruiting
Molecular Analysis of Endoscopic Cytology Samples Supernatant in Pulmonary Nodules
Lung Cancer, Lung; Node
Not yet recruitingObservational study
Diaphragm Ultrasound and Neuromuscular Monitoring for Predicting Early Respiratory Events After Extubation
Residual Neuromuscular Blockade, Diaphragm Dysfunction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
YAO-WEN KUO, Ph.D contact
YEN-LIN CHEN, Doctor of Medicine principal investigator
National Taiwan University Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Lung Ultrasound and Lung Cancer (Diagnosis), run by National Taiwan University Hospital at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 7 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact YEN-LIN CHEN, Doctor of Medicine (+886-2312-3456 ext. 262905, moich.chen@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
volume of measured lesion (time frame: from enrollment, every 6 weeks until 24th week). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2026.